Du Qiang, Geller David A
Department of Surgery, T.E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA.
For Immunopathol Dis Therap. 2010;1(3):155-181. doi: 10.1615/ForumImmunDisTher.v1.i3.
Cross-regulation between the Wnt and nuclear factor (NF)-κB signaling pathways has emerged as an important area for the regulation of a diverse array of genes and pathways active in chronic inflammation, immunity, development, and tumorigenesis. The ligands, kinases, transcription factors, and products of their target gene expression are involved in cross-regulation of these two signaling pathways. Both β-catenin and NF-κB activate inducible nitric oxide synthase (iNOS) gene expression; however, β-catenin also exerts an inhibitory effect on NF-κB-mediated transcriptional activation, including iNOS. The recent discovery of functional cross-regulation between these two pathways has shown complex roles for Wnt/β-catenin and NF-κB signaling in the pathogenesis of certain cancers and other diseases. This review focuses on the molecular mechanisms of cross-regulation between Wnt/β-catenin and NF-κB signaling pathways in cancer cells.
Wnt信号通路与核因子(NF)-κB信号通路之间的交叉调控已成为一个重要领域,用于调控在慢性炎症、免疫、发育和肿瘤发生过程中活跃的各种基因和信号通路。这两条信号通路的配体、激酶、转录因子及其靶基因表达产物均参与交叉调控。β-连环蛋白和NF-κB均可激活诱导型一氧化氮合酶(iNOS)基因表达;然而,β-连环蛋白对NF-κB介导的转录激活(包括iNOS)也具有抑制作用。这两条信号通路之间功能性交叉调控的最新发现表明,Wnt/β-连环蛋白和NF-κB信号在某些癌症和其他疾病的发病机制中具有复杂作用。本综述重点关注癌细胞中Wnt/β-连环蛋白与NF-κB信号通路交叉调控的分子机制。